Drug-eluting stent makers began a massive public relations campaign while the FDA met about the safety of the devices. Johnson & Johnson and Boston Scientific Corp., making use of the FDA's neutral-to-positive verdict on stents, have held numerous conference calls, taken out newspaper ads and sent e-mails to health care professionals to reassure doctors and patients about the drug-coated stents.

Related Summaries